Redhawk Wealth Advisors Inc. Sells 116 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Redhawk Wealth Advisors Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 13.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 758 shares of the healthcare conglomerate’s stock after selling 116 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $383,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. WINTON GROUP Ltd bought a new position in UnitedHealth Group during the second quarter worth about $228,000. Renaissance Technologies LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $36,323,000. Sienna Gestion raised its stake in UnitedHealth Group by 2,619.2% during the second quarter. Sienna Gestion now owns 21,074 shares of the healthcare conglomerate’s stock worth $10,727,000 after acquiring an additional 20,299 shares in the last quarter. First Eagle Investment Management LLC boosted its stake in shares of UnitedHealth Group by 963.5% in the 2nd quarter. First Eagle Investment Management LLC now owns 411,381 shares of the healthcare conglomerate’s stock valued at $209,500,000 after purchasing an additional 372,701 shares in the last quarter. Finally, Miramar Capital LLC increased its position in shares of UnitedHealth Group by 7.5% during the 2nd quarter. Miramar Capital LLC now owns 23,325 shares of the healthcare conglomerate’s stock worth $11,878,000 after purchasing an additional 1,627 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $626.79.

Get Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Stock Down 6.0 %

UnitedHealth Group stock opened at $511.02 on Friday. The company’s 50 day simple moving average is $553.38 and its 200 day simple moving average is $562.98. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market capitalization of $470.28 billion, a price-to-earnings ratio of 33.29, a PEG ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.